Skip to content

The association study of genetic polymorphism on the propofol clinical response

The association study of genetic polymorphism on the propofol clinical response

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039432
Enrollment
Unknown
Registered
2020-10-28
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic surgery patients

Interventions

Case series:Nil

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) age over 18 years old, less than 45 years old, body mass index 18 - 28kg/m2; (2) ASA I-II level; (3) Intravenous general anesthesia, hysteroscopy; (4) Informed consent, voluntary participation and signature of informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with abnormal hepatorenal function; (2) patients with severe cardiopulmonary diseases (cardio-cerebrovascular accidents in recent 6 months); (3) pregnant; (4) patients with mental disease; (5) patients with arrhythmia complicated with hemodynamic instability; (6) patients with allergy to propofol; (7) History of drug abuse.

Design outcomes

Primary

MeasureTime frame
Observer's Assessment of Alertness/Sedation Scale;Gene;

Countries

China

Contacts

Public ContactOuyang Wen

The Third Xiangya Hospital of Central South University

ouyangwen133@vip.sina.com+86 18975183003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026